The emerging functions of endocannabinoid signaling during CNS development

被引:296
作者
Harkany, Tibor [1 ]
Guzman, Manuel
Galve-Roperh, Ismael
Berghuis, Paul
Devi, Lakshmi A.
Mackie, Ken
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, SE-17177 Stockholm, Sweden
[2] Univ Complutense Madrid, Fac Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain
[3] CUNY Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA
[4] CUNY Mt Sinai Sch Med, Dept Biol Chem, New York, NY 10029 USA
[5] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA
[6] Univ Washington, Dept Physiol, Seattle, WA 98195 USA
[7] Univ Washington, Dept Biophys, Seattle, WA 98195 USA
关键词
D O I
10.1016/j.tips.2006.12.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the postnatal brain, endocannabinoids acting as retrograde messengers regulate the function of many synapses. By contrast, the understanding of endocannabinoid functions that regulate fundamental developmental processes such as cell proliferation, migration, differentiation and survival during patterning of the CNS is just beginning to unfold. Increasing the knowledge of basic developmental and signaling principles that are controlled by endocannabinoids will provide important insights into the molecular mechanisms that establish functional neuronal circuits in the brain. Moreover, determining the molecular basis of permanent modifications to cellular structure and intercellular communication imposed by cannabis smoking during pregnancy will provide novel therapeutic targets for alleviating pathogenic changes in affected offspring. Here, we summarize recent findings regarding the ontogeny of the endocannabinoid system in neurons that sculpt the temporal and spatial diversity of cellular functions during CNS development.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 71 条
[11]  
2-R
[12]   Targeting the endocannabinoid system in cancer therapy: A call for further research [J].
Bifulco, M ;
Di Marzo, V .
NATURE MEDICINE, 2002, 8 (06) :547-550
[13]   Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors [J].
Bilkei-Gorzo, A ;
Racz, I ;
Valverde, O ;
Otto, M ;
Michel, K ;
Sarstre, M ;
Zimmer, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15670-15675
[14]   Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain [J].
Bisogno, T ;
Howell, F ;
Williams, G ;
Minassi, A ;
Cascio, MG ;
Ligresti, A ;
Matias, I ;
Schiano-Moriello, A ;
Paul, P ;
Williams, EJ ;
Gangadharan, U ;
Hobbs, C ;
Di Marzo, V ;
Doherty, P .
JOURNAL OF CELL BIOLOGY, 2003, 163 (03) :463-468
[15]   The expanding field of cannabimimetic and related lipid mediators [J].
Bradshaw, HB ;
Walker, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (04) :459-465
[16]   Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides [J].
Cravatt, BF ;
Giang, DK ;
Mayfield, SP ;
Boger, DL ;
Lerner, RA ;
Gilula, NB .
NATURE, 1996, 384 (6604) :83-87
[17]   Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase [J].
Cravatt, BF ;
Demarest, K ;
Patricelli, MP ;
Bracey, MH ;
Giang, DK ;
Martin, BR ;
Lichtman, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9371-9376
[18]   G-protein-coupled receptor dimers in the lime light [J].
Devi, LA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (09) :324-326
[19]   Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice:: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain [J].
Di Marzo, V ;
Breivogel, CS ;
Tao, Q ;
Bridgen, DT ;
Razdan, RK ;
Zimmer, AM ;
Zimmer, A ;
Martin, BR .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2434-2444
[20]   Plant, synthetic, and endogenous cannabinoids in medicine [J].
Di Marzo, V ;
De Petrocellis, L .
ANNUAL REVIEW OF MEDICINE, 2006, 57 :553-574